このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

分娩中の薄暗い光の影響:痛み、不安、分娩進行への影響 (DIM-LIGHT)

2026年9月26日 更新者:Pınar Erdoğan

分娩中の微弱光(≦80ルクス)曝露が疼痛、不安、分娩進行に及ぼす影響:単施設ランダム化比較試験

The environment of the labor room may influence how women experience childbirth. Light levels, in particular, may affect comfort, stress, and the course of labor. However, there is limited high-quality evidence on whether keeping the labor room lighting dim has measurable benefits for mothers.

This study aims to evaluate the effects of dim light exposure during active labor on pain, anxiety, and labor progress. Pregnant women who are in active labor at term will be randomly assigned to one of two groups. One group will give birth in a room with dim lighting (50-80 lux), while the other group will receive standard room lighting as part of routine care.

Pain and anxiety levels will be measured at specific time points during labor using standard assessment scales. Information about labor duration, use of labor medications, mode of delivery, and newborn outcomes will also be collected.

The dim light intervention does not interfere with routine obstetric care and does not pose additional risk to the mother or baby. If needed for clinical reasons, room lighting can be increased immediately. The results of this study may help determine whether a simple change in the birth environment can improve maternal comfort and labor outcomes.

調査の概要

詳細な説明

This study is a single-center, parallel-group randomized controlled trial designed to evaluate the effects of dim light exposure during active labor on maternal pain, anxiety, and labor progress. The trial is conducted in a university hospital labor ward and includes term pregnant women in active labor.

Eligible participants are women aged 18-45 years with a singleton, vertex-presenting pregnancy at ≥37 weeks of gestation who are in active labor. Eligible participants are individually randomized in a 1:1 ratio to either the dim-light intervention group or the standard-light control group using a predefined randomization sequence. Randomization is performed at the participant level after confirmation of eligibility and informed consent.

In the intervention group, labor room lighting is adjusted to a dim light environment with an illumination level maintained between 50 and 80 lux, using warm white or amber light sources. Light intensity is monitored at regular intervals using a lux meter. In the control group, routine labor room lighting conditions are maintained in accordance with standard clinical practice.

Pain intensity and anxiety levels are assessed at predefined time points during labor using validated measurement tools. Labor progress and obstetric outcomes, including use of labor augmentation, duration of labor stages, mode of delivery, and neonatal outcomes, are recorded from clinical charts.

The primary outcome is derived from changes in pain intensity over time during labor. Secondary outcomes include anxiety levels, labor characteristics, and maternal and neonatal clinical outcomes.

The dim light intervention is non-invasive and does not interfere with routine obstetric care. For clinical or safety reasons, room lighting can be increased immediately at any time at the discretion of the clinical team. All participants receive standard intrapartum care according to institutional protocols.

Study data are collected prospectively and stored in an anonymized format to ensure participant confidentiality. The study is conducted in accordance with ethical principles and has received approval from the relevant institutional ethics committee.

研究の種類

介入

入学 (実際)

120

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Niğde Province
      • Niğde、Niğde Province、トルコ(Türkiye)
        • Niğde Ömer Halisdemir University Hospital

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~45年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

女性

説明

Inclusion Criteria:

Pregnant individuals aged 18-45 years

Singleton pregnancy

Vertex (cephalic) presentation

Gestational age ≥37 weeks

Active labor at enrollment (cervical dilation between 4 and 8 cm)

Ability to provide written informed consent

Exclusion Criteria:

Planned or ongoing epidural analgesia

Multiple pregnancy

Severe preeclampsia or other obstetric complications requiring immediate intervention

Known photosensitivity or light-related sensitivity disorders

History of psychiatric disorders that may interfere with anxiety assessment

Any condition deemed by the clinical team to require deviation from the study protocol

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Dim Light (50-80 Lux)

Labor room lighting will be maintained at 50-80 lux using warm white/amber light sources. Illumination will be monitored at regular intervals with a lux meter. Standard intrapartum care will be provided; lighting may be increased immediately if clinically needed.

Adjustment of labor room illumination to a target range of 50-80 lux during active labor, with monitoring using a lux meter; lighting can be increased at any time for clinical reasons.

アクティブコンパレータ:Routine Lighting (Control)

Routine labor room lighting will be maintained according to standard clinical practice. Standard intrapartum care will be provided.

Standard labor room lighting conditions maintained according to routine clinical practice, without modification of illumination levels.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Pain intensity over time (VAS-AUC, 0-120 minutes)
時間枠:From baseline to 120 minutes during active labor

Pain intensity will be assessed using a 0-10 Visual Analog Scale (VAS) at baseline (0 minutes), 60 minutes, and 120 minutes after allocation. The area under the curve (AUC) for VAS from 0 to 120 minutes will be calculated as the primary outcome.

From baseline to 120 minutes during active labor

二次結果の測定

結果測定
メジャーの説明
時間枠
Anxiety level (six-item short-form state anxiety score)
時間枠:From baseline to 90 minutes during active labor

State anxiety was assessed at baseline (prior to intervention/exposure) and at 90 minutes during active labor using a six-item short form derived from the State scale of the State-Trait Anxiety Inventory (STAI). Each item was rated on a four-point scale, with positively worded items reverse-scored. Item scores were summed to yield a raw total score ranging from 6 to 24, with higher scores indicating greater state anxiety. The between-group difference in anxiety at 90 minutes was evaluated with adjustment for baseline anxiety score.

From baseline to 90 minutes during active labor
Oxytocin use (initiation rate and total dose)
時間枠:During labor until delivery

Proportion of participants who receive oxytocin augmentation and the total oxytocin dose administered during labor will be recorded from clinical charts.

During labor until delivery
Duration of active phase of labor
時間枠:From enrollment to full dilation

Time from enrollment during active labor to full cervical dilation will be recorded.

From enrollment to full dilation
Duration of second stage of labor
時間枠:From full dilation to delivery

Time from full cervical dilation to delivery will be recorded.

From full dilation to delivery
Mode of delivery
時間枠:At delivery

Vaginal delivery (spontaneous/assisted) and cesarean delivery will be recorded.

At delivery
Estimated blood loss
時間枠:At delivery / immediate postpartum

Estimated maternal blood loss at delivery will be recorded from clinical records.

At delivery / immediate postpartum
Neonatal outcomes (Apgar scores)
時間枠:1 and 5 minutes after birth

Neonatal well-being will be assessed using the Apgar scoring system at 1 and 5 minutes after birth. The Apgar score ranges from 0 to 10, based on five components (heart rate, respiratory effort, muscle tone, reflex irritability, and skin color). Higher Apgar scores indicate better neonatal condition (better outcome). Apgar scores at 1 and 5 minutes will be recorded and analyzed descriptively.

1 and 5 minutes after birth

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年1月6日

一次修了 (実際)

2026年5月29日

研究の完了 (実際)

2026年5月30日

試験登録日

最初に提出

2025年12月16日

QC基準を満たした最初の提出物

2025年12月16日

最初の投稿 (実際)

2025年12月30日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月30日

QC基準を満たした最後の更新が送信されました

2026年9月26日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared due to the sensitive nature of intrapartum clinical data and the absence of participant consent for data sharing beyond the objectives of this study. De-identified aggregate results will be reported through publications.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する